AV-101-003 Inhaled Imatinib Pulmonary Arterial Hypertension Clinical Trial – Follow Up Long
Term Extension (IMPAHCT-FUL).

NCT05557942

Inhaled Imatinib Pulmonary Arterial Hypertension Clinical Trial – Follow Up Long
Term Extension (IMPAHCT-FUL).

Principal Investigator

Sponsor

Aerovate Therapeutics

Aerovate Therapeutics, Inc. is conducting this study to test AV-101 in people with PAH. The goal is to find out what effects, good or bad, AV-101 has on people with PAH over a longer period of time.